Open Now
Contact Information
1680 SE Lyngate Drive Suite 204, Port Saint Lucie, FL, FL 34952
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm
Service Setting
Outpatient
Outpatient detoxification
Outpatient methadone/buprenorphine or naltrexone treatment
Regular outpatient treatment
Type of Care
Substance use treatment
Detoxification
Treatment Approaches
Substance use disorder counseling
Trauma-related counseling
Telemedicine/telehealth therapy
12-step facilitation
Age Groups Accepted
Young Adults
Adults
Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
Assessment/Pre-treatment
Outreach to persons in the community
Complete medical history/physical exam
Screening for tobacco use
Screening for substance use
Detoxification (medical withdrawal) Services
Alcohol Detoxification
Benzodiazepines Detoxification
Opioids detoxification
Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education
Smoking/vaping/tobacco cessation counseling
Individual counseling
Group counseling
Facility Operation (e.g., Private, Public)
Private for-profit organization
Facility Smoking Policy
Smoking permitted in designated area
Gender Accepted
Female
Male
License/Certification/Accreditation
State substance use treatment agency
Council on Accreditation (COA)
Opioid Medications used in Treatment
Buprenorphine
Naltrexone
Language Services
Spanish
Other languages (excluding Spanish)
Other Languages
Creole
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs
Medicare
Cash or self-payment
SAMHSA funding/block grants
Pharmacotherapies
Buprenorphine with naloxone
Buprenorphine without naloxone
Naltrexone (oral)
Clonidine
Non-nicotine smoking/tobacco cessation
Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Other contracted prescribing entity
No formal relationship with prescribing entity
Testing
Drug or alcohol urine screening
HIV testing
STD testing
TB screening
Metabolic syndrome monitoring
Testing for Hepatitis B (HBV)
Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care
Discharge Planning
Naloxone and overdose education
Type of Opioid Treatment
Buprenorphine detoxification
Buprenorphine maintenance
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Lofexidine or Clonidine detoxification
Maintenance service with medically supervised withdrawal after stabilization
